Records 1 - 16
| RAS/RAF mutations and their associations with epigenetic alterations for distinct pathways in Vietnamese colorectal cancer.
Pathology, research and practice 2020 Feb 152898.
Ta To Van, Nguyen Quang Ngoc, Chu Ha Hoang, Truong Van-Long, Vuong Linh Di
| Primary Mutational Landscape Linked with Pre-Docetaxel Lactate Dehydrogenase Levels Predicts Docetaxel Response in Metastatic Castrate-Resistant Prostate Cancer.
European urology focus 2018 Apr .
Hiew Kenneth, Hart Claire A, Ali Adnan, Elliott Tony, Ramani Vijay, Sangar Vijay, Lau Maurice, Maddineni Satish, Brown Mick, Clarke No
| Hereditary breast and ovarian cancer: new genes in confined pathways.
Nature reviews. Cancer 2016 Aug .
Nielsen Finn Cilius, van Overeem Hansen Thomas, Sørensen Claus Storgaa
| Invasion Patterns of Metastatic Extrauterine High-grade Serous Carcinoma With BRCA Germline Mutation and Correlation With Clinical Outcomes.
The American journal of surgical pathology 2015 Nov .
Hussein Yaser R, Ducie Jennifer A, Arnold Angela G, Kauff Noah D, Vargas-Alvarez Hebert A, Sala Evis, Levine Douglas A, Soslow Robert
| Association of BRCA2 variants with cardiovascular disease in Saudi Arabia.
Genetics and molecular research : GMR 2014 13 (2): 3876-84.
Alanazi M, Reddy N P, Shaik J P, Ajaj S A, Jafari A A A, Saeed H, Khan Z, Khan A
| BRCA1 immunohistochemistry in a molecularly characterized cohort of ovarian high-grade serous carcinomas.
The American journal of surgical pathology 2013 Jan 37 (1): 1.
Garg K, Levine DA, Olvera N, Dao F, Bisogna M, Secord AA, Berchuck A, Cerami E, Schultz N, Soslow RA
| Low prevalence of SLX4 loss-of-function mutations in non-BRCA1/2 breast and/or ovarian cancer families.
European journal of human genetics : EJHG 2012 Dec .
de Garibay GR, Díaz A, Gaviña B, Romero A, Garre P, Vega A, Blanco A, Tosar A, Díez O, Pérez-Segura P, Díaz-Rubio E, Caldés T, de la Hoya M
| BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2012 May 25 (5): 740-50.
McAlpine Jessica N, Porter Henry, Köbel Martin, Nelson Brad H, Prentice Leah M, Kalloger Steve E, Senz Janine, Milne Katy, Ding Jiarui, Shah Sohrab P, Huntsman David G, Gilks C Bla
| Alterations in p53, BRCA1, ATM, PIK3CA, and HER2 genes and their effect in modifying clinicopathological characteristics and overall survival of Bulgarian patients with breast cancer.
Journal of cancer research and clinical oncology 2010 Nov 136 (11): 1657-69.
Bozhanov Stefan S, Angelova Svetla G, Krasteva Maria E, Markov Tsanko L, Christova Svetlana L, Gavrilov Ivan G, Georgieva Elena
| A KRAS-variant in ovarian cancer acts as a genetic marker of cancer risk.
Cancer research 2010 Aug 70 (16): 6509-15.
Ratner Elena, Lu Lingeng, Boeke Marta, Barnett Rachel, Nallur Sunitha, Chin Lena J, Pelletier Cory, Blitzblau Rachel, Tassi Renata, Paranjape Trupti, Hui Pei, Godwin Andrew K, Yu Herbert, Risch Harvey, Rutherford Thomas, Schwartz Peter, Santin Alessandro, Matloff Ellen, Zelterman Daniel, Slack Frank J, Weidhaas Joanne
| Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2009 Jun .
Shaw PA, Rouzbahman M, Pizer ES, Pintilie M, Begley H
| Histopathological findings and follow-up after prophylactic mastectomy and immediate breast reconstruction in 100 women from families with hereditary breast cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2008 Oct 34 (10): 1148-54.
Isern A E, Loman N, Malina J, Olsson H, Ringberg
| The R72P P53 mutation is associated with familial breast cancer in Jewish women.
British journal of cancer 2005 Mar 92 (6): 1144-8.
Ohayon T, Gershoni-Baruch R, Papa M Z, Distelman Menachem T, Eisenberg Barzilai S, Friedman
| Impact of germline BRCA1 mutations and overexpression of p53 on prognosis and response to treatment following breast carcinoma: 10-year follow up data.
Cancer 2003 Feb 97 (3): 527-36.
Goffin John R, Chappuis Pierre O, Bégin Louis R, Wong Nora, Brunet Jean-Sébastien, Hamel Nancy, Paradis Ann-Josée, Boyd Jeff, Foulkes William
| Detection of the most frequent mutations in BRCA1 gene on polyacrylamide gels containing Spreadex Polymer NAB.
Neoplasma 2003 50 (4): 246-50.
Janatová M, Pohlreich P, Matous
| Vitamin D receptor gene polymorphisms and male breast cancer risk in Turkish population.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 0 16 (4): 640-5.
Kizildag S, Gulsu E, Bagci O, Yuksel E, Canda